24 Postgraduate Course Bonus Sessions 2021
| Bonus Sessions
Separate Purchase Required – Must be registered for the Postgraduate Course to purchase access to these sessions. (Formerly Learning Luncheons) |
|
| Peri-Procedural Anticoagulation: WWND (What Would Neena Do)? Neena S. Abraham, MD, MSc (Epid), FACG Describe an evidence-based approach for management of peri-procedural anticoagulation – from routine outpatient procedures to therapeutic interventions for GI bleeding. |
|
| Perianal Crohn’s Disease – Evolutions in Management Miguel D. Regueiro, MD, FACG Review the latest management of perianal Crohn’s disease, including novel therapeutics, combined medical and surgical approaches and optimization of therapies. |
|
| CAM and Psychological Therapies for Functional and Inflammatory Bowel Disease Jill K. Deutsch, MD, and Laurie A. Keefer, PhD Apply current evidence-based strategies for functional bowel disease including both pharmacologic and mind-based therapies such as cognitive behavioral therapies and hypnotherapy. |
|
| Hereditary Pancreatic Cancers – Who Should We Screen and How? Yasmin G. Hernandez-Barco, MD Review the role of genetic screening and screening with imaging for pancreatic cancer with a review of the relevant genes and imaging modalities to consider. |
|
| Management of Disorders of the J-Pouch: A Practical Guide Laura E. Raffals, MD, MS, FACG Review approaches to the endoscopic assessment of the J-pouch, common disorders of the pouch, and medical management. |
|
| Nutrition 101 for the Gastroenterologist: A Case-Based Approach John K. DiBaise, MD, FACG Improve recognition of nutrient deficiencies, review modalities of nutrition support, recognize the warning signs of eating disorders, and review optimal dietary interventions for GI disorders. |
|
| Vascular Diseases of the GI Tract Paul Feuerstadt, MD, FACG Discuss the common presentations of the vascular diseases of the GI tract, including colonic ischemia, and acute and chronic mesenteric ischemia. |
|
| PPI Risks – What Should We Be Telling Our Patients in 2021? Paul Moayyedi, MB ChB, PhD, MPH, FACG Review the risks, benefits, and discussions to be held with patients to maximize efficacy and minimize risk of PPI medications. |
|
| Hereditary Colorectal Cancer Syndromes: Strategies for Monitoring and Prevention Carol A. Burke, MD, FACG Review various hereditary colon cancer syndromes, including a practical algorithm for screening and surveillance. |
|
| Diverticular Disease in 2021: Where Are We Now? Lisa L. Strate MD, MPH, FACG Review epidemiology and burden of diverticular disease, optimize management of diverticular complications, and describe treatment strategies for SUDD (symptomatic uncomplicated diverticular disease) and SCAD (segmental colitis associated with diverticula). |
|
| Viral Hepatitis From A-Z Paul Y. Kwo, MD, FACG Review the natural history, diagnosis, and evidence-based management for common and rare etiologies of viral hepatitis. |
|
| Fecal Incontinence – Strategies for 2021 Satish S. C. Rao, MD, PhD, FACG Review the epidemiology and diagnostic approach for fecal incontinence, describe state-of-the-art management in 2021, and future novel/emerging therapies. |
|
| Gastric Intestinal Metaplasia and Gastric Polyps – Optimal Resection and Surveillance Strategies Douglas R. Morgan, MD, MPH, FACG Provide an evidence-based workflow to determine how to monitor gastric intestinal metaplasia, fundic polyps, and hyperplastic polyps. |
|
| SIBO – Optimal Strategies for Testing and Treatment William D. Chey, MD, FACG Review the best testing and treatment strategies for SIBO, as well as differentiating methane versus hydrogen-predominant pathology. |
|
| Autoimmune Hepatitis and Cholangiopathies: Decoding Overlap Syndromes Marlyn J. Mayo, MD, FACG Discuss the epidemiology, diagnosis, and management of autoimmune hepatitis, cholangiopathies, and overlap syndromes, including indications for when to start and stop therapy. |
|
| ID for the GI – GI Presentations of Unusual Infections (Parasitic, Rickettsial, and Atypical Bacterial Infections) Mark S. Riddle, MD, DrPH Review the unusual presentations and manifestations of some rarer causes of gastrointestinal infection. |
|
| Digital Health in Gastroenterology: A New Frontier Brennan M. Spiegel, MD, MSHS, FACG Discuss the role of digital health in gastroenterology, and the implications for research and clinical practice. |
|
| Endoscopic Ultrasound 101– The Basics and the Emerging Role of LAMS for Complex Anatomy and Pancreatobiliary Disorders Seth A. Gross, MD, FACG Review the modality of EUS and the use of luminal apposing metal stents for GI pathology, including LAMS-assisted endoscopic drainage, and when to refer to an interventional gastroenterologist versus referral to a surgeon. |
|
| Interpretation of Esophageal pH Impedance, Manometry: A Case-Based Approach Felice Schnoll-Sussman, MD, FACG Apply a practical approach to interpretation of esophageal pH-impedance and manometry studies. |
|
| Cannabis for Gastrointestinal Disorders: Everything You Wanted to Know, But Were Afraid to Ask Linda Anh B. Nguyen, MD Provide an overview of the endocannabinoid system and identify the role of cannabinoids in the treatment of functional and inflammatory bowel disease. |
|
| Geriatrics and Gastrointestinal Disorders: Is Age Only a Number? Bharati Kochar, MD, MSCR Explain the impact of aging on various GI disorders, discuss the concepts of frailty and polypharmacy, and provide an algorithmic approach to optimally manage geriatric patients with GI disorders. |
|
| Extraintestinal Manifestations in IBD: Beyond the Bowel Anne G. Tuskey, MD, FACG Review epidemiology and management of EIMs, including paradoxical manifestations and hidradenitis suppurativa. |
|
| Benign Liver Masses – How to Image, When to Resect: Maximal Yield and Minimal Patient Inconvenience Joseph Ahn, MD, MS, MBA, FACG Review the differential of benign liver masses, appropriate imaging protocols for diagnosis, and describe indications (if ever) for biopsy and/or resection. |
|
| Challenging IBD Cases – A Discussion With the Experts from IBD Circle Samir A. Shah, MD, FACG, and Jean-Paul Achkar, MD, FACG Apply evidence-based clinical decision-making approaches to various challenging IBD cases encountered by the practicing gastroenterologist. |
